Literature DB >> 21497680

A complicated picture of oxytocin action in the central nervous system revealed.

Robert H Ring1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21497680     DOI： 10.1016/j.biopsych.2011.03.020

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  7 in total

Review 1.  The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans.

Authors:  George A Kenna; Robert M Swift; Thomas Hillemacher; Lorenzo Leggio
Journal:  Neuropsychol Rev       Date:  2012-07-07       Impact factor: 7.444

Review 2.  The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.

Authors:  Meera E Modi; Larry J Young
Journal:  Horm Behav       Date:  2011-12-20       Impact factor: 3.587

3.  Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors.

Authors:  Roger L H Pobbe; Brandon L Pearson; Erwin B Defensor; Valerie J Bolivar; W Scott Young; Heon-Jin Lee; D Caroline Blanchard; Robert J Blanchard
Journal:  Horm Behav       Date:  2011-11-09       Impact factor: 3.587

4.  Simultaneous oxytocin and arg-vasopressin measurements in microdialysates using capillary liquid chromatography-mass spectrometry.

Authors:  Omar S Mabrouk; Robert T Kennedy
Journal:  J Neurosci Methods       Date:  2012-06-16       Impact factor: 2.390

5.  Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.

Authors:  C Hicks; L Ramos; T Reekie; G H Misagh; R Narlawar; M Kassiou; I S McGregor
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Visual systemizing preference in children with autism: A randomized controlled trial of intranasal oxytocin.

Authors:  Lane Strathearn; Sohye Kim; D Anthony Bastian; Jennifer Jung; Udita Iyengar; Sheila Martinez; Robin P Goin-Kochel; Peter Fonagy
Journal:  Dev Psychopathol       Date:  2017-07-17

Review 7.  Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

Authors:  Craig M Smith; Andrew W Walker; Ihaia T Hosken; Berenice E Chua; Cary Zhang; Mouna Haidar; Andrew L Gundlach
Journal:  Front Pharmacol       Date:  2014-03-21       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.